杜尔洛巴克坦与β-乳酸结合使用,用于对抗Mycobacterium
Eunjeong Shin1,2, Khalid M Dousa1,2, Magdalena A Taracila1,2
1Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA.
Antimicrobial agents and chemotherapy
|December 23, 2024
概括
伊米和杜洛巴克坦的组合有效地通过向必要的细菌酶来对抗Mycobacterium abscessus (Mab). 这种协同疗法提供了一种有希望的新策略来对抗具有挑战性的Mab感染.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于其内在的抵抗机制,Mycobacterium abscessus (Mab) 带来了重大的临床挑战.
- 了解β-乳糖胺和β-乳糖酶抑制剂组合的协同效应对于开发有效治疗方法至关重要.
研究的目的:
- 为了评估beta-lactam和β-lactamase抑制剂组合对Mab的协同效应.
- 阐明协同作用的基本机制,包括目标结合和酶失活.
主要方法:
- 进行了最小抑制度 (MIC) 测试和时间杀戮研究.
- 用质谱和动力学研究评估了beta-lactams和β-lactamase抑制剂与L,D-transpeptidases (LDTs) 和青素结合蛋白 (PBPs) 的结合亲和性.
- 分析了热稳定性和形态变化.
主要成果:
- 伊米胺对LDT和PBP具有很高的结合亲和力,抑制常数非常低.
- 杜洛巴克坦比阿维巴克坦更强烈地禁用了BlaMab和LDT/PBPs,结合常数低于临床度.
- 组合药物,特别是伊米佩内姆+杜尔洛巴克坦,几乎彻底消除了马布,效果优于目前的治疗方法.
结论:
- 这项研究表明了组合治疗的机制基础,突出了伊米佩涅姆+杜尔洛巴克坦作为对抗β-乳酸胺耐药的马布的有效策略.
- 杜罗巴克塔姆对酶的高度亲和力和伊米佩内姆的疗效为克服Mab耐药性提供了坚实的基础.
- 这项研究为针对难以治疗的Mab感染的新型治疗方法铺平了道路.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...


